Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112574081B reveals a mild, high-yield route for aryl thioamides using benzyl alcohol and sulfur. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Patent CN103242372B reveals efficient iridium adducts for aryl ketone synthesis. Enables cost reduction and scalable supply chain for pharmaceutical intermediates.
Patent CN111302990A reveals a mild Pd-catalyzed radical alkenylation for conjugated dienes, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel catalytic route for high-purity fluoroquinolone intermediates. Reduces alkali usage and boosts yield to 82.5% via one-pot synthesis.
Novel hydroxide-based synthesis offers high selectivity and cost reduction for pharmaceutical intermediates supply chain stability and commercial scalability ensuring reliable sourcing.
Patent CN111910206A reveals a metal-free electrochemical route for 3-cyano-imidazoquinolines. Discover cost-effective manufacturing and high-purity pharmaceutical intermediates.
Patent CN113061091B reveals a green Cu-Co/Al2O3 catalytic route for N-alkylation. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN115850337B reveals novel manganese complex for alcohol dehydroalkenylation. Enables cost reduction and scalable supply chain for high-purity olefin intermediates.
Patent CN108484461A reveals metal-free thioamide synthesis. Enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.
Patent CN110015981B details a CuI-catalyzed three-component synthesis of functionalized thioethers. This method offers mild conditions, high yields, and significant cost reduction in pharmaceutical manufacturing.
Patent CN110015981B details a novel CuI-catalyzed three-component reaction for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing.
Patent CN115785052B reveals high-selectivity isocoumarin synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN109970789B reveals a metal-free route for triarylphosphine intermediates, offering significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN103420901A reveals a green, non-metal catalyzed route to 1,2-dihydropyridines, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101163698B reveals efficient Pd-catalyzed coupling and reductive amination routes for 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide, offering significant supply chain advantages.
Discover a novel metal-free amidation method via patent CN111039813B. Achieve cost reduction in pharmaceutical manufacturing with mild conditions and high yields.
Patent CN1646541A details a solvent-free hydrogenation route for aminoorganosilanes, offering significant cost reduction and supply chain reliability for silicone coupling agent manufacturing.
Patent CN107253967A enables transition-metal-free silylation for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Novel Pd/Ag catalyzed CO2 fixation route for high-purity polyimide monomers. Reduces waste and cost significantly for electronic chemical manufacturing.
Patent CN111909038A introduces a safe, low-pressure Schiff base catalyzed route for phenylenediamine, offering significant cost and safety advantages over traditional nitration.